Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Nishida

Showing results (141-150 of 164) with videos related to

Pageof 17
Sort By:
American Journal of Hematology|May 12, 2025
Optimal Depth of the Treatment Response Before Allogeneic Hematopoietic Transplantation for Chronic Myeloid Leukemia in Chronic PhaseYosuke Okada, Takeshi Kondo, Takuya Miyazaki, et al.
Journal of Hematology|September 9, 2024
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic AnemiaHirofumi Yokota, Kotaro Miyao, Masashi Sawa, et al.
Cancer|November 5, 2024
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationYosuke Okada, Noriaki Tachi, Yutaka Shimazu, et al.
British Journal of Haematology|October 23, 2024
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemiaMakoto Moriguchi, Hirohisa Nakamae, Mitsutaka Nishimoto, et al.
Leukemia|December 10, 2024
Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERGSatoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, et al.
Blood Advances|February 2, 2026
The role of HLA transcription in unrelated hematopoietic cell transplantationSatoko Morishima, Takashi Shiina, Fumihiro Azuma, et al.
Transplantation and Cellular Therapy|December 11, 2023
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission StatusTakaaki Konuma, Satoshi Yamasaki, Ken Ishiyama, et al.
Communications Medicine|November 25, 2024
Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patientsTomoyasu Jo, Kosuke Inoue, Tomoaki Ueda, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Pageof 17

Showing results (141-150 of 164) with videos related to

Sort By:
Pageof 17
American Journal of Hematology|May 12, 2025
Optimal Depth of the Treatment Response Before Allogeneic Hematopoietic Transplantation for Chronic Myeloid Leukemia in Chronic PhaseYosuke Okada, Takeshi Kondo, Takuya Miyazaki, et al.
Journal of Hematology|September 9, 2024
Long-Term Outcome of Eltrombopag With First-Line Immunosuppressive Therapy for Newly Diagnosed Severe Aplastic AnemiaHirofumi Yokota, Kotaro Miyao, Masashi Sawa, et al.
Cancer|November 5, 2024
Comparing de novo chronic myeloid leukemia in blastic phase with Philadelphia chromosome-positive acute lymphoblastic leukemia after allogeneic hematopoietic cell transplantationYosuke Okada, Noriaki Tachi, Yutaka Shimazu, et al.
British Journal of Haematology|October 23, 2024
Comparison of HLA-haploidentical donors with post-transplant cyclophosphamide versus HLA-matched unrelated donors in peripheral blood stem cell transplantation for acute myeloid leukaemiaMakoto Moriguchi, Hirohisa Nakamae, Mitsutaka Nishimoto, et al.
Leukemia|December 10, 2024
Allogeneic hematopoietic stem cell transplantation in adult acute myeloid leukemia with t(16;21)(p11;q22)/FUS::ERGSatoshi Mitsuyuki, Yoshimitsu Shimomura, Hiroki Mizumaki, et al.
Blood Advances|February 2, 2026
The role of HLA transcription in unrelated hematopoietic cell transplantationSatoko Morishima, Takashi Shiina, Fumihiro Azuma, et al.
Transplantation and Cellular Therapy|December 11, 2023
Comparison of Allogeneic Transplant Outcomes Between Matched Sibling Donors and Alternative Donors in Patients Over 50 Years of Age with Acute Myeloid Leukemia: 8/8 Allele-Matched Unrelated Donors and Unrelated Cord Blood Provide Better Leukemia-Free Survival Compared with Matched Sibling Donors During Nonremission StatusTakaaki Konuma, Satoshi Yamasaki, Ken Ishiyama, et al.
Communications Medicine|November 25, 2024
Machine learning evaluation of intensified conditioning on haematopoietic stem cell transplantation in adult acute lymphoblastic leukemia patientsTomoyasu Jo, Kosuke Inoue, Tomoaki Ueda, et al.
American Journal of Hematology|May 1, 2025
Improved Transplant Outcomes With Alternative Donors in Myelofibrosis: A 20-Year Japanese Registry Analysis of Donor Sources and the Impact of RuxolitinibKazuki Sakatoku, Hirohisa Nakamae, Makoto Murata, et al.
Annals of Hematology|April 14, 2026
Donor selection for patients with HLA-homozygous haplotypes in allogeneic hematopoietic stem cell transplantationNoriyoshi Yoshinaga, Makoto Iwasaki, Koji Kato, et al.
Pageof 17